Medicare Enrolled

Dr. Saritha Kortikere, MD

Family Medicine · Longview, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
805 MEDICAL CIRCLE DR, Longview, TX 75605
9032328100
In practice since 2006 (19 years)
NPI: 1760427173 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kortikere from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kortikere? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kortikere

Dr. Saritha Kortikere is a family medicine in Longview, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kortikere performed 4,159 Medicare services across 2,762 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kortikere received a total of $12,470 from 58 pharmaceutical and/or device companies across 929 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kortikere is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in TX$ $12,470 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,159
Medicare services
Top 5% in TX for family medicine
2,762
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)634$78$200
Complete blood count (CBC) with differential326$8$40
Comprehensive metabolic blood panel324$10$105
Thyroid stimulating hormone (TSH) test311$16$70
Lipid panel (cholesterol and triglycerides)309$13$66
Blood draw (venipuncture)266$8$20
Dexamethasone injection (steroid)244$0$0
Annual wellness visit, follow-up220$125$130
Office visit, established patient (20-29 min)165$55$135
Chronic care management, first 20 min/month141$43$65
Drug injection, under skin or into muscle134$9$50
Hemoglobin A1c test (diabetes monitoring)133$9$60
Chest X-ray, 2 views87$15$64
Ceftriaxone antibiotic injection85$0$8
Prostate cancer screening; prostate specific antigen test (psa)76$19$95
Injection, methylprednisolone acetate, 80 mg57$8$20
Flu vaccine administration49$30$31
Flu vaccine, high-dose48$72$85
3D screening mammography (tomosynthesis)47$23$71
Screening mammography47$86$300
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow47$79$150
Urine culture, bacterial colony count46$8$35
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a41$31$70
Detection test by immunoassay with direct visual observation for influenza virus39$16$45
Urinalysis with microscopic exam37$3$22
Transitional care management services for problem of high complexity35$213$410
Antibiotic sensitivity test31$8$40
Urinalysis, manual24$3$20
Urine culture, bacterial identification22$8$20
Chronic care management, additional 20 min/month22$35$50
Automated urinalysis18$2$18
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus17$35$65
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and15$40$80
Knee X-ray, 3 views14$21$88
X-ray of abdomen, 1 view13$12$59
Shoulder X-ray, 2+ views12$18$71
Foot X-ray, 3+ views12$18$74
Diagnostic mammography of 1 breast11$54$253
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,470
Total received (2018-2024)
Avg $1,781/year across 7 years
Top 3% in TX for family medicine
58
Companies
929
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,437 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,593
2023
$2,201
2022
$1,872
2021
$1,748
2020
$1,117
2019
$1,969
2018
$1,969

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,641
Amgen Inc.
$1,184
GlaxoSmithKline, LLC.
$1,044
Lilly USA, LLC
$866
PFIZER INC.
$843
AstraZeneca Pharmaceuticals LP
$836
Boehringer Ingelheim Pharmaceuticals, Inc.
$667
ABBVIE INC.
$589
Janssen Pharmaceuticals, Inc
$373
Novartis Pharmaceuticals Corporation
$348
Merck Sharp & Dohme LLC
$332
AbbVie Inc.
$313
Amarin Pharma Inc.
$286
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$250
Otsuka America Pharmaceutical, Inc.
$241
Merck Sharp & Dohme Corporation
$217
Teva Pharmaceuticals USA, Inc.
$208
Astellas Pharma US Inc
$204
Takeda Pharmaceuticals U.S.A., Inc.
$199
Allergan Inc.
$198
Radius Health, Inc.
$179
SANOFI-AVENTIS U.S. LLC
$125
Exact Sciences Corporation
$124
Bayer HealthCare Pharmaceuticals Inc.
$118
Biohaven Pharmaceutical Holding Company Ltd.
$74
MERZ NORTH AMERICA, INC.
$70
Allergan, Inc.
$66
ITI, Inc.
$66
Lundbeck LLC
$60
Kowa Pharmaceuticals America, Inc.
$58
Abbott Laboratories
$55
Dynavax Technologies Corporation
$54
Jazz Pharmaceuticals Inc.
$42
Avanir Pharmaceuticals, Inc.
$40
Phathom Pharmaceuticals, Inc.
$37
ARBOR PHARMACEUTICALS, INC.
$36
Sumitomo Pharma America, Inc.
$35
Synergy Pharmaceuticals Inc
$33
Bioventus LLC
$33
BOSTON SCIENTIFIC CORPORATION
$32
Daiichi Sankyo Inc.
$28
Corcept Therapeutics
$24
Antares Pharma, Inc.
$22
Xeris Pharmaceuticals, Inc.
$19
Almatica Pharma LLC
$18
Orexigen Therapeutics, Inc.
$18
INOGEN, INC.
$17
Flexion Therapeutics, Inc.
$16
Tris Pharma Inc
$16
IRONWOOD PHARMACEUTICALS, INC
$15
Eisai Inc.
$14
Ironwood Pharmaceuticals, Inc
$14
GE HEALTHCARE
$14
Sunovion Pharmaceuticals Inc.
$14
IDORSIA PHARMACEUTICALS US INC
$13
Shire North American Group Inc
$12
AbbVie, Inc.
$11
Horizon Pharma plc
$11
Top 3 companies account for 31.0% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · AUSTEDO · Aimovig · Amitiza · Androgel · Austedo XR · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CAPLYTA · CELEBREX · CHANTIX · CONTRAVE · Cologuard Collection Kit · DUZALLO · Dayvigo · Durolane · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Evekeo · FARXIGA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · GELSYN-3 · GEMTESA · GRALISE · GVOKE PFS · Heplisav-B · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MYDAYIS · Myrbetriq · NOCDURNA · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Otovel · Ozempic · PENNSAID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · STEGLATRO · SYMBICORT · SYNJARDY · SYNVISC-ONE · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · Vyvanse · WATCHMAN · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · Xyrem · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in TX.

Equivalent to $300 per 100 Medicare services performed
Looking for a family medicine in Longview?
Compare family medicines in the Longview area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
81
Per 100K population
64.9
County median income
$64,809
Nearest hospital
LONGVIEW REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kortikere is a clinical cardiology specialist, with above-average Medicare volume (top 5% in TX), and high industry engagement (low-engagement, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kortikere experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kortikere performed 634 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kortikere receive payments from pharmaceutical companies?
Yes. Dr. Kortikere received a total of $12,470 from 58 companies across 929 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kortikere's costs compare to other family medicines in Longview?
Dr. Kortikere's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kortikere) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →